CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
University of Sydney
Sídney, AustraliaPublications in collaboration with researchers from University of Sydney (28)
2024
-
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review
Frontiers in Immunology, Vol. 15
2023
-
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883
-
Ravulizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Annals of Neurology, Vol. 93, Núm. 6, pp. 1053-1068
-
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644
2022
-
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Frontiers in Immunology, Vol. 13
-
Multiple sclerosis in the era of COVID-19: Disease course, DMTs and SARS-CoV2 vaccinations
Current Opinion in Neurology, Vol. 35, Núm. 3, pp. 319-327
-
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
Frontiers in Immunology, Vol. 13
2021
-
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
Journal of Neurology, Vol. 268, Núm. 11, pp. 3961-3968
-
Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Neurology, Vol. 96, Núm. 24, pp. E2989-E3002
2019
-
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
Multiple Sclerosis and Related Disorders, Vol. 28, pp. 235-243
2017
-
Contribution of different relapse phenotypes to disability in multiple sclerosis
Multiple Sclerosis, Vol. 23, Núm. 2, pp. 266-276
-
Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response
Brain, Vol. 140, Núm. 9, pp. 2426-2443
2016
-
Defining secondary progressive multiple sclerosis
Brain, Vol. 139, Núm. 9, pp. 2395-2405
-
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 87, Núm. 12, pp. 1343-1349
-
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study
The Lancet Neurology, Vol. 15, Núm. 6, pp. 574-584
2015
-
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 9, pp. 1159-1171
-
Comparative efficacy of switching to natalizumab in active multiple sclerosis
Annals of Clinical and Translational Neurology, Vol. 2, Núm. 4, pp. 373-387
-
Defining reliable disability outcomes in multiple sclerosis
Brain, Vol. 138, Núm. 11, pp. 3287-3298
-
Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS
PLoS ONE, Vol. 10, Núm. 6
-
Predictors of disability worsening in clinically isolated syndrome
Annals of Clinical and Translational Neurology, Vol. 2, Núm. 5, pp. 479-491